Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) dropped 1.5% during trading on Thursday . The company traded as low as $0.14 and last traded at $0.14. Approximately 813 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 10,628 shares. The stock had previously closed at $0.15.
Guided Therapeutics Price Performance
The stock has a 50 day moving average of $0.17 and a 200 day moving average of $0.15. The firm has a market cap of $9.30 million, a price-to-earnings ratio of -4.76 and a beta of 0.58.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
See Also
- Five stocks we like better than Guided Therapeutics
- Transportation Stocks Investing
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
